Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc
C., & Stefanski, A., for the SURMOUNT-1 Investigators
It can act as a gasoline on a fire when it comes to cell growth
Over the past five years, the global weight-loss drug market has evolved from GLP-1 single-target to dual-target therapies, driving peptides from early research into large-scale commercial development
However, if side effects persist or worsen, consult a healthcare professional for advice
The kidney and cardiovascular effects of current and next-generation incretin and metabolic hormone therapies remain an area of active investigation